FDA Approved: NELARABINE — Original Application (XGen Pharmaceuticals DJB, Inc.)

View source ↗

Summary

FDA approved the original application for nelarabine as a generic drug, with XGen Pharmaceuticals DJB, Inc. listed as the manufacturer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia
• T-cell Lymphoblastic Lymphoma

Drugs mentioned

• Nelarabine (Nelarabine)

Snippet

ORIG AP for NELARABINE (NELARABINE)